Showing results (51-60 of 216) with videos related to

Sort By:
Pageof 22
Oncotarget|June 4, 2015
Lapatinib promotes the incidence of hepatotoxicity by increasing chemotherapeutic agent accumulation in hepatocytesChunLing Dai, ShaoLin Ma, Fang Wang, et al.
Materials (Basel, Switzerland)|June 28, 2023
The Portevin-Le Chatelier Effect of Cu-2.0Be Alloy during Hot CompressionDaibo Zhu, Na Wu, Yang Liu, et al.
Materials Today. Bio|September 9, 2022
Visualization system based on hierarchical targeting for diagnosis and treatment of hepatocellular carcinomaShasha Shi, Huipu Li, Xi Zheng, et al.
Journal of Hematology & Oncology|August 17, 2021
Anticancer bispecific antibody R&D advances: a study focusing on research trend worldwide and in ChinaZhonghan Zhang, Fan Luo, Jiaxin Cao, et al.
Cancer Control : Journal of the Moffitt Cancer Center|June 29, 2021
Clinical Significance of Kinetics of Low-Density Lipoprotein Cholesterol and Its Prognostic Value in Limited Stage Small Cell Lung Cancer PatientsTingting Liu, Ting Zhou, Fan Luo, et al.
Journal of Biomaterials Applications|April 30, 2023
The study of self-regulating α-TCP based composite by micro/nano scaled silk fibroin and α-CSH on physicochemical and biological properties of bone cementYaping Song, Liqin Zhao, Baolong Niu, et al.
Frontiers in Public Health|June 13, 2022
Automated Multi-View Multi-Modal Assessment of COVID-19 Patients Using Reciprocal Attention and Biomedical TransformYanhan Li, Hongyun Zhao, Tian Gan, et al.
Scientific Reports|January 9, 2015
The effectiveness of RECIST on survival in patients with NSCLC receiving chemotherapy with or without target agents as first-line treatmentTing Zhou, Lie Zheng, Zhihuang Hu, et al.
Oncotargets and Therapy|November 23, 2012
The impact of tumor size change after target therapy on survival: analysis of patients enrolled onto three clinical trials of advanced NSCLC from one institutionJianwei Zhang, Yan Huang, Xiaoling Li, et al.
Annals of Translational Medicine|July 30, 2019
Modification of the tumor response threshold in patients of advanced non-small cell lung cancer treated with chemotherapy plus targeted agents: a pooled study from five clinical trials in one institutionFan Luo, Zhonghan Zhang, Kunlun Liao, et al.
Pageof 22